Michael Neal Blackburn

Title: Michael Neal Blackburn: Innovator in Coagulation Research

Introduction

Michael Neal Blackburn is a prominent inventor based in Phoenixville, PA (US). He has made significant contributions to the field of coagulation research, particularly through his innovative work on monoclonal antibodies. With a total of 2 patents, Blackburn's inventions have the potential to impact medical treatments related to thrombosis.

Latest Patents

Blackburn's latest patents include groundbreaking developments in the area of coagulation factors. His first patent focuses on anti-factor IX/IXa antibodies, which are monoclonal antibodies directed against coagulation factors and their use in inhibiting thrombosis. The second patent involves nucleic acids encoding immunoglobulin domains, which also pertain to monoclonal antibodies aimed at inhibiting thrombosis.

Career Highlights

Throughout his career, Blackburn has worked with notable organizations such as SmithKline Beecham Corporation and the University of Vermont and State Agricultural College. His experience in these institutions has allowed him to refine his research and contribute to advancements in medical science.

Collaborations

Some of Blackburn's notable coworkers include William Robert Church and Giora Zeev Feuerstein. Their collaborative efforts have further enhanced the research and development of innovative solutions in the field of coagulation.

Conclusion

Michael Neal Blackburn's contributions to coagulation research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments for thrombosis.